Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × elacestrant × Clear all

Phase

Status

Recruiting 7 Completed 3 Active not recruiting 3 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Endometrial Stromal 1 Perivascular Epithelioid Cell Neoplasms 1 Breast Neoplasms 1 Breast Cancer Patients 1 Adenosarcoma of the uterus 1

Interventions

Capecitabine 16 Trastuzumab 13 pertuzumab 12 Letrozole 11 Docetaxel 11 Cyclophosphamide 11 pyrotinib 9 Paclitaxel 9 Carboplatin 9 sacituzumab govitecan 7 palbociclib 7 abemaciclib 7 Fulvestrant 7 trastuzumab deruxtecan 6 Tamoxifen 6 Radiotherapy 6 Epirubicin 6 Drug Therapy 6 Anastrozole 6 eribulin 5 dalpiciclib 5 Vinorelbine 5 Standard of Care 5 Neoadjuvant Therapy 5 exemestane 4 Sentinel Lymph Node Biopsy 4 Gemcitabine 4 Doxorubicin 4 ribociclib 3 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07242352 2025-11-21

ADAPTela

West German Study Group

Phase 3 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡